|
|
(STOCK SYMBOL - CDNX, "HED")
Hedley Announces Results
for the Fourth Quarter 2001
We have audited the
consolidated balance sheet of Hedley Technologies Ltd. as at
We conducted our audit in accordance with generally accepted auditing standards. Those standards require that we plan and perform an audit to obtain reasonable assurance whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.
In our opinion, these financial statements present fairly, in all material respects, the financial position of the Company as at December 31, 2001 and the results of its operations and its cash flows for the year then ended in accordance with generally accepted accounting principles.
As required by the Company
Act of British Columbia, we report that, in our opinion, these principles have
been applied on a basis consistent with those of the preceding year.
Consolidated Financial Highlights
For the year
ended
Canadian $
|
Hedley Technologies Ltd. |
||
|
Consolidated Balance Sheet |
||
|
As at |
||
|
|
||
|
|
2001 |
2000 |
|
|
||
|
Assets |
||
|
Current |
||
|
Cash |
$ 74,918 |
$ 62,226 |
|
Accounts receivable |
1,781,138 |
136,824 |
|
Inventories |
80,695 |
71,105 |
|
Prepaid expenses |
1,113 |
457 |
|
|
||
|
|
1,937,864 |
270,612 |
|
|
||
|
|
||
|
Patents, trademarks and deferred development costs(Note 3) |
237,072 |
311,773` |
|
|
||
|
|
||
|
Deferred market development costs(Note 4) |
52,070 |
107,482 |
|
|
||
|
|
||
|
Capital assets(Note 5) |
31,741 |
41,681 |
|
|
||
|
|
||
|
Long-term investment |
- |
442,963 |
|
|
||
|
|
$ 2,258,747 |
$ 1,174,511 |
|
|
||
|
Liabilities |
||
|
Current |
||
|
Accounts payable and accrued liabilities |
$ 767,886 |
$ 464,151 |
|
Notes payable(Note 6) |
500,000 |
500,000 |
|
|
||
|
|
1,267,886 |
964,151 |
|
|
||
|
Shareholders' Equity |
||
|
Share capital(Note 7b) |
6,440,328 |
6,440,328 |
|
|
||
|
|
||
|
Contributed surplus |
23,755 |
23,755 |
|
|
||
|
|
||
|
Deficit |
(5,473,222) |
(6,253,723) |
|
|
||
|
|
990,861 |
210,360 |
|
|
||
|
|
$ 2,258,747 |
$ 1,174,511 |
|
|
||
|
Hedley Technologies Ltd. |
||
|
Consolidated Statement of Operations and Deficit |
||
|
Year
ended |
||
|
|
||
|
|
2001 |
2000 |
|
|
||
|
Revenue |
||
|
Sales |
$ 665,934 |
$ 887,310 |
|
Cost of sales |
260,835 |
293,113 |
|
|
||
|
Gross profit |
405,099 |
594,197 |
|
Consulting revenue |
- |
- |
|
|
||
|
|
405,099 |
594,197 |
|
|
||
|
Expenses |
||
|
Salaries and benefits |
230,678 |
346,513 |
|
Selling and marketing |
145,363 |
148,430 |
|
Travel and accommodation |
27,507 |
57,493 |
|
Communications |
29,401 |
46,258 |
|
Interest and bank charges |
128,098 |
68,574 |
|
Legal and accounting |
24,927 |
54,132 |
|
Office |
10,971 |
16,339 |
|
Rent |
14,300 |
24,246 |
|
Financing charge |
- |
2,903 |
|
Equipment rental |
2,849 |
8,232 |
|
Printing |
2,311 |
5,896 |
|
Warehousing |
8,424 |
4,186 |
|
Transfer agent and filing fees |
6,143 |
9,418 |
|
Foreign exchange loss(gain) |
(4,326) |
(6,432) |
|
Bad debts |
201 |
149 |
|
Amortization |
232,920 |
217,398 |
|
|
||
|
|
859,767 |
1,003,735 |
|
|
||
|
Loss from operations |
(454,668) |
(409,538) |
|
|
||
|
Other |
||
|
Gain on settlement of debt |
45,110 |
- |
|
Gain on sale of assets |
1,190,059 |
- |
|
Other income |
- |
4,069 |
|
|
||
|
|
1,235,169 |
4,069 |
|
|
||
|
Income (Loss) for the year |
780,501 |
(405,469) |
|
Deficit, beginning of year |
(6,253,723) |
(5,848,254) |
|
|
||
|
Deficit, end of year |
$ (5,473,222) |
$ (6,253,723) |
|
|
||
|
Gain (Loss) per share |
$0.09 |
(0.04) |
|
|
||
|
Hedley Technologies Ltd. |
|||
|
Consolidated Statement of Cash Flows |
|||
|
Year
ended |
|||
|
|
|||
|
|
2001 |
2000 |
|
|
|
|||
|
Cash provided by(used for) |
|||
|
Operating activities |
|||
|
Loss for the year |
$ 780,501 |
$ (405,469) |
|
|
Item not involving cash |
|||
|
Amortization |
232,920 |
217,398 |
|
|
Loss on Disposal of Asset |
- |
5,200 |
|
|
Changes in non-cash working capital items |
|||
|
Accounts receivable |
(1,644,314) |
(119,258) |
|
|
Inventory |
(9,590) |
30,473 |
|
|
Prepaid expenses |
(656) |
1,566 |
|
|
Accounts payable |
303,735 |
144,020 |
|
|
|
|||
|
Decrease from operating activities |
(337,404) |
(126,070) |
|
|
|
|||
|
Financing activities |
|||
|
Notes payable |
- |
- |
|
|
Special warrants issued(exercised), net of issue costs |
- |
- |
|
|
shares issued, net of costs |
- |
- |
|
|
|
|||
|
Increase from financing activities |
- |
- |
|
|
|
|||
|
Investing activities |
|||
|
Purchase of capital assets |
- |
(12,547) |
|
|
Patents, trademarks and deferred development costs |
(92,867) |
(111,695) |
|
|
|
442,963 |
- |
|
|
|
|||
|
Increase (decrease) from investing activities |
350,096 |
(124,242) |
|
|
|
|||
|
Increase (decrease) in cash for the year |
12,692 |
(250,312) |
|
|
Cash, beginning of year |
62,226 |
312,538 |
|
|
|
|||
|
Cash, end of year |
$ 74,918 |
$ 62,226 |
|
|
|
|||
1. Basis of presentation
These consolidated
financial statements present the accounts of Hedley Technologies Ltd. (the
"Company") and its two wholly owned subsidiaries, Hedley
Technologies (USA) Inc. and HTI Agritech Inc.
Hedley Technologies (USA) Inc. (formerly HTI Agritech
(USA) Inc.) was incorporated on May 13, 1994 in the state of Washington, USA.
HTI Agritech was incorporated on
All intercompany transactions have been eliminated in the consolidated financial statements. The accounts of Hedley Technologies (USA) Inc. have been consolidated using the temporal method of foreign currency translation.
2. Significant accounting policies
(a) Patent, trademarks and deferred development costs
Costs related to the acquisition of rights, product development and testing, and obtaining regulatory approval, net of related grants, have been capitalized. These costs are being amortized against related revenues from commercial production and sales on a straight line basis over five years.
(b) Deferred market development costs
Certain
costs related to market development in markets outside of
(c) Capital assets and amortization
Capital assets are stated at cost. The Company records amortization of capital assets at the following rates and methods:
|
Furniture |
20% declining balance |
|
Equipment |
20% declining balance |
|
Mould and design drawings |
20% declining balance |
|
Computer equipment |
30% declining balance |
|
Leasehold improvements |
5 year straight line |
|
Software |
30% straight line |
Amortization is calculated at one half of the above noted rates in the year of acquisition.
(d) Inventories
Finished goods and raw materials are stated at the lower of cost and net realizable value.
(e) Foreign currency translation
Amounts denominated in foreign currencies have been translated into Canadian dollars as follows:
i. Monetary assets and liabilities at the rate of exchange prevailing at the balance sheet date;
ii. Non-monetary assets and liabilities at the rate of exchange prevailing at the time of acquisition of the assets or assumption of the liabilities; and
iii. Revenue and expenses at rates approximating the rates of exchange prevailing on the transaction dateexcept for amortization, which is translated at the same rate as the assets to which it relates.
Gains or losses on translation are included in current year's operations.
(f) Use of estimates by management
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Significant areas requiring the use of estimates include the valuation of patents, trademarks and deferred development costs and deferred market development costs (Notes 3 and 4).
3. Patents, trademarks and deferred development costs
In 1992, the Company acquired the patent and distribution rights to a line of non-toxic insecticides marketed under the trade name INSECOLO™, subject to a 3% royalty on product sales. A minimum royalty of $10,000 is payable annually.
The Company holds a 50% patent ownership and 100% of the licensed rights to distribute a non-toxic insecticide marketed under the name PROTECT-ITŪ. The Company must pay a royalty of 2% of sales of the product annually.
The balance of this account
is analyzed as follows:
|
|
||
|
|
2001 |
2000 |
|
|
||
|
Cost |
||
|
Balance at beginning of year |
$ 745,079 |
$ 633,385 |
|
|
||
|
Additions during the year: |
||
|
Trademark and patent registration |
- |
- |
|
Product research and development |
166,296 |
142,379 |
|
Government grants |
(73,401) |
(30,685) |
|
|
||
|
|
92,895 |
111,694 |
|
|
||
|
Balance at end of year |
837,974 |
745,079 |
|
|
||
|
Accumulated amortization |
||
|
Balance at beginning of year |
433,306 |
284,290 |
|
amortization expense |
167,596 |
149,016 |
|
|
||
|
Balance at end of year |
600,902 |
433,306 |
|
|
||
|
Net book value |
$ 237,072 |
$ 311,773 |
|
|
||
4. Deferred market development costs
The balance of this account
is analyzed as follows:
|
|
||
|
|
2001 |
2000 |
|
|
||
|
Cost |
||
|
Balance at beginning of year |
$ 277,021 |
$ 277,021 |
|
|
||
|
Additions during the year: |
||
|
Salaries and consulting fees |
- |
- |
|
Government grants |
- |
- |
|
|
||
|
|
- |
- |
|
|
||
|
Balance at end of year |
277,021 |
277,021 |
|
|
||
|
Accumulated amortization |
||
|
Balance at beginning of year |
169,539 |
114,130 |
|
amortization expense |
55,412 |
55,409 |
|
|
||
|
Balance at end of year |
224,951 |
169,539 |
|
|
||
|
Net book value |
$ 52,070 |
$ 107,482 |
|
|
||
5. Capital assets
Capital assets consist of
the following:
|
|
||||
|
|
|
2001 |
|
2000 |
|
|
||||
|
|
Cost |
Accumulated |
Net book |
Net
Book |
|
|
||||
|
Furniture |
$ 33,021 |
$ 24,684 |
$ 8,337 |
$ 10,422 |
|
Equipment |
25,199 |
18,216 |
6,983 |
8,729 |
|
Mould and design drawings |
11,700 |
4,879 |
6,821 |
8,526 |
|
Computer equipment |
60,650 |
51,514 |
9,136 |
13,052 |
|
Leasehold improvements |
1,253 |
873 |
380 |
630 |
|
Software |
805 |
724 |
81 |
322 |
|
|
||||
|
|
$ 132,628 |
$ 100,890 |
$ 31,738 |
$41,681 |
|
|
||||
6. Note payable
The note payable of $500,000 is due on September 15, 2000 and bears interest at the rate of 12% per annum on the outstanding principal amount. All shares of Philom Bios Inc., as described in Note 6, and all assets of the Company have been pledged as security in respect of this financing.
The Company is in default
of certain covenants with respect to this financing. On
Subsequent to the date of the consolidated financial statements, the company paid of the loan and $ 213,376 of accrued interest.
7. Share capital
(a) The authorized share capital of the Company consists of 100,000,000 common shares without par value and 25,000,000 preferred shares without par value.
(b) The issued outstanding share capital of the Company is set out below:
|
|
||||
|
|
2001 |
2000 |
||
|
|
||||
|
|
Number |
Amount |
Number |
Amount |
|
|
||||
|
Balance at beginning of year |
9,170,195 |
$6,440,328 |
9,920,195 |
$6,440,328 |
|
|
||||
|
Issued during the year |
|
|
|
|
|
Escrow shares(net) |
- |
- |
- |
- |
|
Settlement of debt |
- |
- |
- |
- |
|
Acquisition of investment |
- |
- |
- |
- |
|
Financing fee |
- |
- |
- |
- |
|
Special warrants exercised |
- |
- |
- |
- |
|
for shares(net of issue costs) |
- |
- |
- |
- |
|
|
||||
|
Balance at end of year |
$ 9,170,195 |
$ 6,440,328 |
$ 9,920,195 |
$ 6,440,328 |
|
|
||||
(c) Stock options
The Company has granted stock options to certain directors and employees of the Company entitling them to acquire common shares of the Company as follows:
|
Number of shares |
Exercise price |
Expiry date |
|
|
|
|
||
|
200,000 |
$0.10 |
|
|
|
200,000 |
$0.10 |
|
|
|
70,000 |
$0.10 |
|
|
|
170,000 |
$0.10 |
|
|
|
70,000 |
$0.10 |
|
|
|
20,000 |
$0.10 |
|
|
|
70,000 |
$0.10 |
|
|
|
55,000 |
$0.10 |
|
|
|
45,000 |
$0.10 |
|
|
|
|
|
||
|
900,000 |
|
|
|
(d) Loss per share
Loss per share is calculated based on the weighted average number of shares outstanding during the year of 9,170,195 shares.
8. Related party transaction
On June 9, 1999 the Company borrowed $500,000 from a group of investment funds holding shares in the Company. During the year, interest of $108,791 (2000 - $60,000) were charged to operations
9. Income taxes
As at
10. Lease commitments
The company is committed
under operating lease agreements for the rental of real property and certain
equipment. The leases expire on
A summary of the
commitments is as follows:
|
2002 |
$ 16,323 |
|
2003 |
15,566 |
|
2004 |
1,305 |
|
|
|
|
|
$ 33,194 |
|
|
|
11. Financial instruments and concentration of risk
The carrying values of cash, accounts receivable, long-term investment, accounts payable and accrued liabilities and notes payable approximate their respective fair values.
It is management's opinion
that the Company is not exposed to significant interest, currency or credit
risks arising from these financial statements
All figures unless otherwise noted are reported in accordance with Canadian Generally Accepted Accounting Principles.
Please visit the SEDAR home page for a more detailed account of our filings.
[Corporate Overview] [Products&Services] [What's New] [Investor Relations] [News Release] [Technology] [Home Page]